US · Healthcare · Biotechnology
EPS came in at -0.41 against a street estimate of -0.39 — a miss of 5.1%.
Analysts rate Creative Medical Technology Holdings Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $20.00.
| Fund | Stake |
|---|---|
| Hudson Bay Capital Management LP | 1.78% |
| Anson Funds Management LP | 1.39% |
| Armistice Capital, LLC | 0.55% |
| XTX Topco Ltd | 0.35% |
| Geode Capital Management, LLC | 0.34% |
| Vanguard Capital Management, LLC | 0.27% |
| Vanguard Fiduciary Trust Co | 0.07% |
| Tower Research Capital LLC | 0.06% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Creative Medical Technology Holdings Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.